BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
BRBS
Blue Ridge Bankshares, Inc.
There isn't enough reported data to score BRBS yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BRBS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
BRBS's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like BRBS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
BRBS PE Valuation
BRBS has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
BRBS Forward outlook
There aren't enough analyst estimates for BRBS to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus BRBS down 100%.
BRBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$0.92 | +$1.74 |
| Q2 2024 | -$3.11 | -$2.78 |
| Q1 2024 | -$3.09 | -1817% |
| Q4 2023 | -$2.73 | -397% |
| Q3 2023 | -$2.66 | -232% |
| Q2 2023 | -$0.33 | -115% |
| Q1 2023 | $0.18 | -95% |
BRBS is still losing money, but far less than before: $0.00 per share over the past year, against $3.11 at its worst in mid-2024.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over BRBS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over BRBS on profitability, with a higher operating margin.
BRBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20M | -22% |
| Q2 2026 | $18.3M | -21% |
| Q1 2026 | $19.3M | -13% |
| Q4 2025 | $20.8M | -4.7% |
| Q3 2025 | $25.7M | +18% |
| Q2 2025 | $23.1M | +13% |
| Q1 2025 | $22.1M | -22% |
| Q4 2024 | $21.8M | -16% |
BRBS's revenue has slid since its 2021 peak: $20M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -22% | -51 points |
| Q2 2026 | -8.9% | -17 points |
| Q1 2026 | 5.8% | +9.8 points |
| Q4 2025 | 26% | +38 points |
| Q3 2025 | 29% | +22 points |
| Q2 2025 | 7.7% | +67 points |
| Q1 2025 | -4% | +7.7 points |
| Q4 2024 | -12% | +17 points |
BRBS's operating margin was −22% last quarter, down 51 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BRBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.5M | -21% |
| Q2 2026 | $1.5M | -86% |
| Q1 2026 | $14.6M | +$18.2M |
| Q4 2025 | -$699K | +$17.5M |
| Q3 2025 | $5.7M | -76% |
| Q2 2025 | $10.5M | +$15.5M |
| Q1 2025 | -$3.6M | +$4M |
| Q4 2024 | -$18.2M | -190% |
BRBS's free cash flow was $20M over the past year, against −$6M the year before. Free cash flow isn't a meaningful measure for financial services companies like BRBS.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BRBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +127K shares |
| 1 year | -11% | -10.8M shares |
| 3 years | +370% | +69.8M shares |
| 5 years | +375% | +70M shares |
BRBS has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $6.7M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over BRBS on leverage, with a lower net debt burden relative to earnings.
BRBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 89.6x | High |
| Q2 2026 | 7.5x | High |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 6.2x | High |
| Q2 2025 | 37.9x | High |
| Q1 2023 | 7.9x | High |
| Q4 2022 | 11.4x | High |
BRBS's net debt is more than 20 years of its operating earnings (EBITDA), up from 6.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BRBS.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BRBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 67.1 | Neutral |
BRBS's weekly RSI is 58 (neutral) and its Stochastic is 67 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BRBS on valuation relative to its sector.
BRBS PE vs Financial Services Sector
| Metric | BRBS | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 13x | 184% above |
| PE % | 92 | 63 | 29 pts above |
BRBS has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BRBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.95 | 2% above |
| 20 week MA | $3.81 | 5.8% above |
| 50 week MA | $3.88 | 3.9% above |
| 100 week MA | $3.77 | 6.9% above |
| 200 week MA | $4.53 | 11% below |
BRBS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
BRBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.7 | $11.9 | -13% |
| 2021 | $11.9 | $17.8 | +49% |
| 2022 | $17.8 | $12.4 | -30% |
| 2023 | $12.4 | $3.03 | -76% |
| 2024 | $3.03 | $3.19 | +5.3% |
| 2025 | $3.19 | $4.37 | +37% |
| 2026 YTD | $4.37 | $4.03 | -7.8% |
BRBS has the edge over BAC on returns for 2026, with the stronger performance.